MedTech Venture Partners

What MedTech Venture Partners does

MedTech Venture Partners (legal name: Medical Technology Venture Partners) is a Menlo Park, California-based venture capital firm founded in 2015 that invests exclusively in seed and Series A medical device companies. The firm deploys initial checks of $500,000 to $3 million into developers of novel therapeutic and diagnostic devices that have reached advanced prototype stage with supporting bench and animal data, and follows up in subsequent rounds with comparable amounts. The firm derives revenue through conventional VC economics: management fees on managed fund capital and carried interest from portfolio company exits, with no disclosed AUM or fund size.

The firm's current portfolio of approximately 10 companies spans diverse medtech categories including wearable neuromodulation (Cala Health), targeted radiation therapy (GT Medical Technologies), intelligent surgical drainage (Centese), clinical data analytics (Verana Health), benign prostatic hyperplasia implants (Zenflow), thrombectomy devices (Thrombx Medical), and ultrasound-based drug delivery (Suono Bio). Three portfolio exits have been realized: Novonate (acquired by Laborie), ReLign (acquired by Zimmer Biomet), and Siris Medical. The firm does not operate a traditional sales channel; deal sourcing is driven by partner networks and an online application process at medtechvp.com.

The core differentiator is human capital. Founding Partner Peter Loescher is the former President and CEO of Siemens AG and former President of Global Human Health at Merck & Co. Partner Thomas Glanzmann previously served as CEO of Gambro and HemoCue and as President of Baxter Bioscience. Partner & Managing Director Radu Cautis was part of the Gambro executive team. The team also includes CFO Stephen Bonelli (former CFO of Align Technology and 5AM Ventures), regulatory specialist Javad Seyedzadeh (ex-Gambro, Siemens Healthcare), and clinical pulmonologist Ajay Dharia (UCSF-trained). The firm supplements this core with investment advisors including Brook Byers (KPCB co-founder), Josh Makower (NEA General Partner), and Casey Tansey (USVP General Partner), plus a clinical advisory bench drawn from UCSF faculty. Combined team experience accounts for over 30 medical device and diagnostic product launches.

Name

MedTech Venture Partners

Legal name

Medical Technology Venture Partners

Website

https://medtechvp.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

11–50 employees

Short description

MedTech Venture Partners is a Menlo Park-based seed and Series A venture capital firm investing $500K–$3M in novel therapeutic and diagnostic medical device companies, supported by a partner team with prior CEO experience at Siemens, Gambro, Baxter, and Merck.

Ownership category

akta.pro rank

Product category

Venture Capital / Medical Technology Investment

NAICS

Portfolio Management and Investment Advice (523940)

SIC

Investment Advice (6282)

akta.pro primary industry

Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)

Keywords

• Medical device venture capital
• Seed stage investing
• Healthcare early stage funding
• Medical device startups
• Therapeutic diagnostics investment

Headquarters

HQ city

Menlo Park

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Fund Management: VC firm generates returns through management fees on managed funds and carried interest from successful portfolio company exits.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

MedTech Venture Partners is a venture capital firm that provides seed and Series A financing ($500,000 to $3 million) to early-stage companies developing novel therapeutic and diagnostic medical devices. The firm invests in startups with advanced prototypes, strong bench data, and animal data, and provides active operational, clinical, and regulatory support through its partner network.

Product overview

MedTech Venture Partners is a venture capital firm that provides investment services to medical technology entrepreneurs. The firm operates as a single investment service offering, funding novel therapeutic and diagnostic medical devices at seed or A-round stages with investments between $500 thousand and $3 million, with follow-up in later rounds. Their portfolio consists of companies developing various medical technologies including wearable neuromodulation devices, targeted radiation therapy systems, surgical drainage systems, clinical data analytics platforms, and implants. The firm leverages its team's experience overseeing the conception, development, and launch of over 30 medical devices and diagnostics products.

Differentiator

Problem solved

Functional benefit

Products and services

• Medical Device Seed and Series A Investment Venture capital investment in early-stage medical device and diagnostics companies, providing $500,000 to $3 million in initial seed or A-round funding with follow-on participation in later rounds, plus active support through partner operations and industry expertise.

Quantifiable outcome

• Over 30 medical devices and diagnostics products conceived, developed, and launched

Named customers10 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators3 records

Recent moves4 records

Expansion highlights3 records

Direct peers

• The Foundry: Medtech-focused incubator and venture firm in Menlo Park that creates, funds, and operates early-stage medical device companies. Highly comparable in operating model, geography, and stage focus; The Foundry's co-founder Hanson Gifford is also an MTVP Investment Advisor.
• Versant Ventures: Healthcare-dedicated venture firm with deep medical device and biotechnology franchises. Comparable as a sector-specialist investor underwriting early-stage medtech opportunities and syndicating with strategic capital partners.
• 5AM Ventures: Early-stage life sciences venture firm investing in therapeutic and platform technologies with an operator-led model. Highly comparable stage focus and life sciences specialization; MTVP CFO Stephen Bonelli previously served as CFO of 5AM Ventures.
• MVM Partners: Specialist medical device and life sciences growth equity firm focused exclusively on commercial-stage and growth-stage medtech. Comparable as a dedicated medtech investor participating alongside MTVP in deals such as GT Medical's Series E.
• Evidity Health Capital: Healthcare-focused investment firm that has led rounds in medical device companies including GT Medical Technologies' Series D. Comparable as a dedicated healthcare/medtech investor co-investing with MTVP.
• Accelmed Partners: Medical device-focused private equity and venture firm. Comparable as a specialist medtech capital provider co-investing alongside MTVP in GT Medical's Series D.

Broad incumbents

• U.S. Venture Partners (USVP): Larger multi-stage venture firm with a long-standing medical device franchise. Comparable in medtech focus but broader scope across enterprise, consumer, and life sciences; Investment Advisor Casey Tansey is a USVP general partner.
• New Enterprise Associates (NEA): One of the largest venture firms with a dedicated healthcare team investing across therapeutics, devices, and digital health. Comparable in healthcare investing breadth and scale; MTVP Investment Advisor Josh Makower leads NEA's medtech practice.
• Kleiner Perkins: Major venture firm with a long-running digital health and life sciences practice. Comparable in medtech investing history; MTVP Investment Advisor Brook Byers is a founding partner of Kleiner Perkins.

Regional players

• Gilde Healthcare: European healthcare specialist investor with a medtech and therapeutics focus. Comparable as a sector-dedicated investor that has co-invested with MTVP in GT Medical's Series E, but primarily European-domiciled deals.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments25 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MedTech Venture Partners